Skip to main content
Top
Published in: Seminars in Immunopathology 3-4/2004

01-02-2004 | Original Paper

Effects of intestinal microflora and the environment on the development of asthma and allergy

Author: Bengt Björkstén

Published in: Seminars in Immunopathology | Issue 3-4/2004

Login to get access

Abstract

The aim of previous research into the causes of allergic diseases, including asthma was mostly to identify potential risk factors in the environment. No major risk factors have been identified, however. Over the past 10 years, focus has, therefore, more been directed towards protective factors that could enhance the development of tolerance to allergens which were previously encountered early in life, but are now lost in modern affluent societies. In particular, the role of childhood infections has been discussed, but so far these studies have not been conclusive. Recent epidemiological studies and experimental research suggest that the microbial environment and exposure to microbial products in infancy modifies immune responses and enhances the development of tolerance to ubiquitous allergens. The intestinal microflora may play a particular role in this respect, as it is the major external driving force in the maturation of the immune system after birth, and animal experiments have shown it to be a prerequisite for normal development of oral tolerance. Recent studies have shown differences in the composition of the microflora between healthy and allergic infants in countries with a high and low prevalence of allergies and between healthy and allergic infants within such countries. These differences are apparent within the first week of life and thus precede clinical symptoms. The use of live microorganisms that might be beneficial to health has a long tradition and the safety is well documented. Very recently, several prospective intervention studies, modifying the gut flora from birth have yielded encouraging results and may suggest a new mode of primary prevention of allergy in the future.
Literature
1.
go back to reference Adlerberth I, Jalil F, Carlsson B, et al (1998) High turnover rate of Escherichia coli strains in the intestinal flora of infants in Pakistan. Epidemiol Infect 121:587 Adlerberth I, Jalil F, Carlsson B, et al (1998) High turnover rate of Escherichia coli strains in the intestinal flora of infants in Pakistan. Epidemiol Infect 121:587
2.
go back to reference Alm JS, Lilja G, Pershagen G, Scheynius A (1997) Early BCG vaccination and development of atopy. Lancet 350:400 Alm JS, Lilja G, Pershagen G, Scheynius A (1997) Early BCG vaccination and development of atopy. Lancet 350:400
3.
go back to reference Anyo G, Brunekreef B, Meer G de, Aarts F, Janssen NA, Vliet P van (2002) Early, current and past pet ownership: associations with sensitization, bronchial responsiveness and allergic symptoms in school children. Clin Exp Allergy 32:361 Anyo G, Brunekreef B, Meer G de, Aarts F, Janssen NA, Vliet P van (2002) Early, current and past pet ownership: associations with sensitization, bronchial responsiveness and allergic symptoms in school children. Clin Exp Allergy 32:361
4.
go back to reference Azizi BH, Zulkifli HI, Kasim MS (1995) Protective and risk factors for acute respiratory infections in hospitalized urban Malaysian children: a case control study. Southeast Asian J Trop Med Public Health 26:280 Azizi BH, Zulkifli HI, Kasim MS (1995) Protective and risk factors for acute respiratory infections in hospitalized urban Malaysian children: a case control study. Southeast Asian J Trop Med Public Health 26:280
5.
go back to reference Baldini M, Lohman I, Halonen M, Erickson R, Holt P, Martinez F (1999) A polymorphism in the 5’-flanking region of the CD14 gene is associated with circulating soluble CD14 levels with total serum IgE. Am J Respir Cell Mol Biol 20:976 Baldini M, Lohman I, Halonen M, Erickson R, Holt P, Martinez F (1999) A polymorphism in the 5’-flanking region of the CD14 gene is associated with circulating soluble CD14 levels with total serum IgE. Am J Respir Cell Mol Biol 20:976
6.
go back to reference Benn CS, Thorsen P, Jensen JS, et al (2002) Maternal vaginal microflora during pregnancy and the risk of asthma hospitalization and use of antiasthma medication in early childhood. J Allergy Clin Immunol 110:72 Benn CS, Thorsen P, Jensen JS, et al (2002) Maternal vaginal microflora during pregnancy and the risk of asthma hospitalization and use of antiasthma medication in early childhood. J Allergy Clin Immunol 110:72
7.
go back to reference Björkstén B (1983) Does breast-feeding prevent the development of allergy? Immunol Today 4:215 Björkstén B (1983) Does breast-feeding prevent the development of allergy? Immunol Today 4:215
8.
go back to reference Björkstén B (1999) Allergy priming early in life. Lancet 353:167 Björkstén B (1999) Allergy priming early in life. Lancet 353:167
9.
go back to reference Björkstén B, Naaber P, Sepp E, Mikelsaar M (1999) The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 29:342 Björkstén B, Naaber P, Sepp E, Mikelsaar M (1999) The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 29:342
10.
go back to reference Björkstén B, Sepp E, Julge K, Voor T, Mikelsaar M (2001) Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 108:516 Björkstén B, Sepp E, Julge K, Voor T, Mikelsaar M (2001) Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 108:516
11.
go back to reference Borriello S, Hammes W, Holzapfel W, et al (2003) Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 36:775 Borriello S, Hammes W, Holzapfel W, et al (2003) Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 36:775
12.
go back to reference Böttcher MF, Nordin EK, Sandin A, Midtvedt T, Björkstén B (2000) Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy 30:1590 Böttcher MF, Nordin EK, Sandin A, Midtvedt T, Björkstén B (2000) Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy 30:1590
13.
go back to reference Böttcher MF, Björkstén B, Gustafson S, Voor T, Jenmalm MC (2003) Endotoxin levels in Estonian and Swedish house dust and atopy in infancy. Clin Exp Allergy 33:295 Böttcher MF, Björkstén B, Gustafson S, Voor T, Jenmalm MC (2003) Endotoxin levels in Estonian and Swedish house dust and atopy in infancy. Clin Exp Allergy 33:295
14.
go back to reference Brandzaeg P (1996) Development of the mucosal immune system in humans. In: Bindels J, Goedhart A, Visser H (eds) Recent developments ininfant nutrition. Kluwer, London, p 349 Brandzaeg P (1996) Development of the mucosal immune system in humans. In: Bindels J, Goedhart A, Visser H (eds) Recent developments ininfant nutrition. Kluwer, London, p 349
15.
go back to reference Bråbäck L (1998) Hedberg A. Perinatal risk factors for atopic disease in conscripts. Clin Exp Allergy 28:936 Bråbäck L (1998) Hedberg A. Perinatal risk factors for atopic disease in conscripts. Clin Exp Allergy 28:936
16.
go back to reference Bullen CL, Tearle PV, Stewart MG (1977) The effect of “humanised” milks and supplemented breast feeding on the faecal flora of infants. J Med Microbiol 10:403 Bullen CL, Tearle PV, Stewart MG (1977) The effect of “humanised” milks and supplemented breast feeding on the faecal flora of infants. J Med Microbiol 10:403
17.
go back to reference Burr ML, Limb ES, Maguire MJ, et al (1993) Infant feeding, wheezing, and allergy: a prospective study. Arch Dis Child 68:724 Burr ML, Limb ES, Maguire MJ, et al (1993) Infant feeding, wheezing, and allergy: a prospective study. Arch Dis Child 68:724
18.
go back to reference Cook DG, Strachan DP (1997) Health effects of passive smoking. 3. Parental smoking and prevalence of respiratory symptoms and asthma in school age children. Thorax 52:1081 Cook DG, Strachan DP (1997) Health effects of passive smoking. 3. Parental smoking and prevalence of respiratory symptoms and asthma in school age children. Thorax 52:1081
19.
go back to reference D’Souza AL, Rajkumar C, Cooke J, Bulpitt CJ (2002) Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 324:1361 D’Souza AL, Rajkumar C, Cooke J, Bulpitt CJ (2002) Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 324:1361
20.
go back to reference Gereda JE, Leung DY, Liu AH (2000) Levels of environmental endotoxin and prevalence of atopic disease. JAMA 284:1652 Gereda JE, Leung DY, Liu AH (2000) Levels of environmental endotoxin and prevalence of atopic disease. JAMA 284:1652
21.
go back to reference Gerrard J, Geddes C, Reggin P, Gerrard C, Horne S (1976) Serum IgE levels in white and metis communities in Saskatchewan. Ann Allergy 37:91 Gerrard J, Geddes C, Reggin P, Gerrard C, Horne S (1976) Serum IgE levels in white and metis communities in Saskatchewan. Ann Allergy 37:91
22.
go back to reference Golding J, Emmett PM, Rogers IS (1997) Eczema, asthma and allergy. Early Hum Dev 49 Suppl:S121 Golding J, Emmett PM, Rogers IS (1997) Eczema, asthma and allergy. Early Hum Dev 49 Suppl:S121
23.
go back to reference Golding J, Emmett PM, Rogers IS (1997) Gastroenteritis, diarrhoea and breast feeding. Early Hum Dev 49 Suppl:S83 Golding J, Emmett PM, Rogers IS (1997) Gastroenteritis, diarrhoea and breast feeding. Early Hum Dev 49 Suppl:S83
24.
go back to reference Gruber C, Nilsson L, Björkstén B (2001) Do early childhood immunizations influence the development of atopy and do they cause allergic reactions? Pediatr Allergy Immunol 12:296 Gruber C, Nilsson L, Björkstén B (2001) Do early childhood immunizations influence the development of atopy and do they cause allergic reactions? Pediatr Allergy Immunol 12:296
25.
go back to reference Halmerbauer G, Gartner C, Schier M, et al (2002) Study on the prevention of allergy in children in Europe (SPACE): allergic sensitization in children at 1 year of age in a controlled trial of allergen avoidance from birth. Pediatr Allergy Immunol 13 Suppl 15:47 Halmerbauer G, Gartner C, Schier M, et al (2002) Study on the prevention of allergy in children in Europe (SPACE): allergic sensitization in children at 1 year of age in a controlled trial of allergen avoidance from birth. Pediatr Allergy Immunol 13 Suppl 15:47
26.
go back to reference Hesselmar B, Åberg N, Åberg B, Eriksson B, Björkstén B (1999) Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy 29:611 Hesselmar B, Åberg N, Åberg B, Eriksson B, Björkstén B (1999) Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy 29:611
27.
go back to reference Holt PG, Sly PD, Björkstén B (1997) Atopic versus infectious diseases in childhood: a question of balance? Pediatr Allergy Immunol 8:53 Holt PG, Sly PD, Björkstén B (1997) Atopic versus infectious diseases in childhood: a question of balance? Pediatr Allergy Immunol 8:53
28.
go back to reference Holzapfel WH, Haberer P, Snel J, Schillinger U, Huis in’t Veld JH (1998) Overview of gut flora and probiotics. Int J Food Microbiol 41:85 Holzapfel WH, Haberer P, Snel J, Schillinger U, Huis in’t Veld JH (1998) Overview of gut flora and probiotics. Int J Food Microbiol 41:85
29.
go back to reference Hooper L, Gordon J (2001) Commensal host-bacterial relationships in the gut. Science 292:1115 Hooper L, Gordon J (2001) Commensal host-bacterial relationships in the gut. Science 292:1115
30.
go back to reference Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ (2002) Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 47:2625 Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ (2002) Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 47:2625
31.
go back to reference Illi S, von Mutius E, Lau S, et al (2001) Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study. Br Med J 322:390 Illi S, von Mutius E, Lau S, et al (2001) Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study. Br Med J 322:390
32.
go back to reference Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S (2000) Probiotics in the management of atopic eczema. Clin Exp Allergy 30:1604 Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S (2000) Probiotics in the management of atopic eczema. Clin Exp Allergy 30:1604
33.
go back to reference Julge K, Vasar M, Björkstén B (2001) Development of allergy and IgE antibodies during the first five years of life in Estonian children. Clin Exp Allergy 31:1854 Julge K, Vasar M, Björkstén B (2001) Development of allergy and IgE antibodies during the first five years of life in Estonian children. Clin Exp Allergy 31:1854
34.
go back to reference Kalliomäki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E (2001) Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 107:129 Kalliomäki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E (2001) Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 107:129
35.
go back to reference Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357:1076 Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357:1076
36.
go back to reference Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E (2003) Probiotics and prevention of atopic disease; 4-year follow-up of a randomised placebo-controlled trial. Lancet 361:1869 Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E (2003) Probiotics and prevention of atopic disease; 4-year follow-up of a randomised placebo-controlled trial. Lancet 361:1869
37.
go back to reference Kandler O (1984) Current taxonomy of lactobacilli. Developments in industrial microbiology, Proc. 40th Gen Meet.Soc.Insustrial Microbiol., Srasota, Florida Kandler O (1984) Current taxonomy of lactobacilli. Developments in industrial microbiology, Proc. 40th Gen Meet.Soc.Insustrial Microbiol., Srasota, Florida
38.
go back to reference Kirjavainen PV, Arvola T, Salminen SJ, Isolauri E (2002) Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut 51:51 Kirjavainen PV, Arvola T, Salminen SJ, Isolauri E (2002) Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut 51:51
39.
go back to reference Kirjavainen PV, Salminen SJ, Isolauri E (2003) Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr 36:223 Kirjavainen PV, Salminen SJ, Isolauri E (2003) Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr 36:223
40.
go back to reference Lau S, Illi S, Sommerfeld C, et al (2000) Early exposure to house-dust mite and cat allergens and development of childhood asthma: a cohort study. Multicentre Allergy Study Group. Lancet 356:1392 Lau S, Illi S, Sommerfeld C, et al (2000) Early exposure to house-dust mite and cat allergens and development of childhood asthma: a cohort study. Multicentre Allergy Study Group. Lancet 356:1392
41.
go back to reference Leynaert B, Neukirch C, Jarvis D, Chinn S, Burney P, Neukirch F (2001) Does living on a farm during childhood protect against asthma, allergic rhinitis, and atopy in adulthood? Am J Respir Crit Care Med 164:1829 Leynaert B, Neukirch C, Jarvis D, Chinn S, Burney P, Neukirch F (2001) Does living on a farm during childhood protect against asthma, allergic rhinitis, and atopy in adulthood? Am J Respir Crit Care Med 164:1829
42.
go back to reference Majamaa H, Isolauri E (1997) Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 99:179 Majamaa H, Isolauri E (1997) Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 99:179
43.
go back to reference Matricardi PM, Rosmini F, Riondino S, et al (2000) Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. Br Med J 320:412 Matricardi PM, Rosmini F, Riondino S, et al (2000) Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. Br Med J 320:412
44.
go back to reference Matricardi PM, Rosmini F, Panetta V, Ferrigno L, Bonini S (2002) Hay fever and asthma in relation to markers of infection in the United States. J Allergy Clin Immunol 110:381 Matricardi PM, Rosmini F, Panetta V, Ferrigno L, Bonini S (2002) Hay fever and asthma in relation to markers of infection in the United States. J Allergy Clin Immunol 110:381
45.
go back to reference Matricardi P, Björkstén B, Bonini S, et al (2003) Microbial products in allergy prevention and therapy. Allergy 58:461 Matricardi P, Björkstén B, Bonini S, et al (2003) Microbial products in allergy prevention and therapy. Allergy 58:461
46.
go back to reference Mevissen-Verhage EA, Marcelis JH, Harmsen-Van Amerongen WC, Vos NM de, Verhoef J (1985) Effect of iron on neonatal gut flora during the first three months of life. Eur J Clin Microbiol 4:273 Mevissen-Verhage EA, Marcelis JH, Harmsen-Van Amerongen WC, Vos NM de, Verhoef J (1985) Effect of iron on neonatal gut flora during the first three months of life. Eur J Clin Microbiol 4:273
47.
go back to reference Mevissen-Verhage EA, Marcelis JH, Harmsen-van Amerongen WC, Vos NM de, Berkel J, Verhoef J (1985) Effect of iron on neonatal gut flora during the first week of life. Eur J Clin Microbiol 4:14 Mevissen-Verhage EA, Marcelis JH, Harmsen-van Amerongen WC, Vos NM de, Berkel J, Verhoef J (1985) Effect of iron on neonatal gut flora during the first week of life. Eur J Clin Microbiol 4:14
48.
go back to reference Mikelsaar M, Annuk H, Stsepetova J, Kullisaar T, Zilmer M, Björkstén B (2002) Intestinal lactoflora of Estonian and Swedish children. Microbiol Ecol Health Dis 14:75 Mikelsaar M, Annuk H, Stsepetova J, Kullisaar T, Zilmer M, Björkstén B (2002) Intestinal lactoflora of Estonian and Swedish children. Microbiol Ecol Health Dis 14:75
49.
go back to reference Nafstad P, Magnus P, Jaakkola JJ (2000) Early respiratory infections and childhood asthma. Pediatrics 106:E38 Nafstad P, Magnus P, Jaakkola JJ (2000) Early respiratory infections and childhood asthma. Pediatrics 106:E38
50.
go back to reference Nagler-Anderson C (2001) Man the barrier! Strategic defences in the intestinal mucosa. Nat Rev Immunol 1:59 Nagler-Anderson C (2001) Man the barrier! Strategic defences in the intestinal mucosa. Nat Rev Immunol 1:59
51.
go back to reference Nagler-Anderson C, Terhoust C, Bhan AK, Podolsky DK (2001) Mucosal antigen presentation and the control of tolerance and immunity. Trends Immunol 22:120 Nagler-Anderson C, Terhoust C, Bhan AK, Podolsky DK (2001) Mucosal antigen presentation and the control of tolerance and immunity. Trends Immunol 22:120
52.
go back to reference Neish AS (2002) The gut microflora and intestinal epithelial cells: a continuing dialogue. Microbes Infect 4:309 Neish AS (2002) The gut microflora and intestinal epithelial cells: a continuing dialogue. Microbes Infect 4:309
53.
go back to reference Nilsson L, Kjellman NI, Lofman O, Björkstén B (1997) Parity among atopic and non-atopic mothers. Pediatr Allergy Immunol 8:134 Nilsson L, Kjellman NI, Lofman O, Björkstén B (1997) Parity among atopic and non-atopic mothers. Pediatr Allergy Immunol 8:134
54.
go back to reference Ouwehand AC, Isolauri E, He F, Hashimoto H, Benno Y, Salminen S (2001) Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol 108:144 Ouwehand AC, Isolauri E, He F, Hashimoto H, Benno Y, Salminen S (2001) Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol 108:144
55.
go back to reference Ownby DR, Johnson CC, Peterson EL (2002) Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age. JAMA 288:963 Ownby DR, Johnson CC, Peterson EL (2002) Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age. JAMA 288:963
56.
go back to reference Peat J, Björkstén B (1998) Primary and secondary prevention of allergic asthma. Eur Respir J Suppl 27:28s Peat J, Björkstén B (1998) Primary and secondary prevention of allergic asthma. Eur Respir J Suppl 27:28s
57.
go back to reference Riedler J, Braun-Fahrländer C, Eder W, et al (2001) Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 358:1129 Riedler J, Braun-Fahrländer C, Eder W, et al (2001) Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 358:1129
58.
go back to reference Rook GA, Stanford JL (1998) Give us this day our daily germs. Immunol Today 19:113 Rook GA, Stanford JL (1998) Give us this day our daily germs. Immunol Today 19:113
59.
go back to reference Roost HP, Kunzli N, Schindler C, et al (1999) Role of current and childhood exposure to cat and atopic sensitization. European Community Respiratory Health Survey. J Allergy Clin Immunol 104:941 Roost HP, Kunzli N, Schindler C, et al (1999) Role of current and childhood exposure to cat and atopic sensitization. European Community Respiratory Health Survey. J Allergy Clin Immunol 104:941
60.
go back to reference Rosenfeldt V, Benfeldt E, Nielsen SD, et al (2003) Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 111:389 Rosenfeldt V, Benfeldt E, Nielsen SD, et al (2003) Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 111:389
61.
go back to reference Sepp E, Julge K, Vasar M, Naaber P, Björkstén B, Mikelsaar M (1997) Intestinal microflora of Estonian and Swedish infants. Acta Paediatr 86:956 Sepp E, Julge K, Vasar M, Naaber P, Björkstén B, Mikelsaar M (1997) Intestinal microflora of Estonian and Swedish infants. Acta Paediatr 86:956
62.
go back to reference Sepp E, Naaber P, Voor T, Mikelsaar M, Björkstén B (2000) Development of intestinal micro-flora during the first month of life in Estonian and Swedish infants. Microbiol Ecol Health Dis 12:22 Sepp E, Naaber P, Voor T, Mikelsaar M, Björkstén B (2000) Development of intestinal micro-flora during the first month of life in Estonian and Swedish infants. Microbiol Ecol Health Dis 12:22
63.
go back to reference Shirakawa T, Enomoto T, Shimazu S, Hopkin JM (1997) The inverse association between tuberculin responses and atopic disorder. Science 275:77 Shirakawa T, Enomoto T, Shimazu S, Hopkin JM (1997) The inverse association between tuberculin responses and atopic disorder. Science 275:77
64.
go back to reference Sigurs N (2002) Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease. Respir Res 3 Suppl 1:S8 Sigurs N (2002) Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease. Respir Res 3 Suppl 1:S8
65.
go back to reference Stene LC, Nafstad P (2001) Relation between occurrence of type 1 diabetes and asthma. Lancet 357:607 Stene LC, Nafstad P (2001) Relation between occurrence of type 1 diabetes and asthma. Lancet 357:607
66.
go back to reference Strachan D (1989) Hay fever, hygiene and household size. Br Med J 299:1259 Strachan D (1989) Hay fever, hygiene and household size. Br Med J 299:1259
67.
go back to reference Strachan D (2000) Family size, infection and atopy: the first decade of the “hygiene hypothesis”. Thorax 55 Suppl 1:S2 Strachan D (2000) Family size, infection and atopy: the first decade of the “hygiene hypothesis”. Thorax 55 Suppl 1:S2
68.
go back to reference Strachan DP (2000) The role of environmental factors in asthma. Br Med Bull 56:865 Strachan DP (2000) The role of environmental factors in asthma. Br Med Bull 56:865
69.
go back to reference Strachan DP, Cook DG (1997) Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax 52:905 Strachan DP, Cook DG (1997) Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax 52:905
70.
go back to reference Strachan DP, Cook DG (1998) Health effects of passive smoking. 6. Parental smoking and childhood asthma: longitudinal and case-control studies. Thorax 53:204 Strachan DP, Cook DG (1998) Health effects of passive smoking. 6. Parental smoking and childhood asthma: longitudinal and case-control studies. Thorax 53:204
71.
go back to reference Strachan DP, Cook DG (1998) Health effects of passive smoking .5. Parental smoking and allergic sensitisation in children. Thorax 53:117 Strachan DP, Cook DG (1998) Health effects of passive smoking .5. Parental smoking and allergic sensitisation in children. Thorax 53:117
72.
go back to reference Strannegård IL, Larsson LO, Wennergren G, Strannegård Ö (1998) Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria. Allergy 53:249 Strannegård IL, Larsson LO, Wennergren G, Strannegård Ö (1998) Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria. Allergy 53:249
73.
go back to reference Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y (1997) The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 159:1739 Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y (1997) The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 159:1739
74.
go back to reference Svanes C, Jarvis D, Chinn S, Burney P (1999) Childhood environment and adult atopy: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 103:415 Svanes C, Jarvis D, Chinn S, Burney P (1999) Childhood environment and adult atopy: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 103:415
75.
go back to reference Van Niel C, Feudtner C, Garrison M, Christakis D (2002) Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 109:678 Van Niel C, Feudtner C, Garrison M, Christakis D (2002) Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 109:678
76.
go back to reference Von Mutius E, Braun-Fahrländer C, Schierl R, et al (2000) Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin Exp Allergy 30:1230 Von Mutius E, Braun-Fahrländer C, Schierl R, et al (2000) Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin Exp Allergy 30:1230
77.
go back to reference Wahn U, Lau S, Bergmann R, et al (1997) Indoor allergen exposure is a risk factor for sensitization during the first three years of life. J Allergy Clin Immunol 99:763 Wahn U, Lau S, Bergmann R, et al (1997) Indoor allergen exposure is a risk factor for sensitization during the first three years of life. J Allergy Clin Immunol 99:763
Metadata
Title
Effects of intestinal microflora and the environment on the development of asthma and allergy
Author
Bengt Björkstén
Publication date
01-02-2004
Publisher
Springer-Verlag
Published in
Seminars in Immunopathology / Issue 3-4/2004
Print ISSN: 1863-2297
Electronic ISSN: 1863-2300
DOI
https://doi.org/10.1007/s00281-003-0142-2

Other articles of this Issue 3-4/2004

Seminars in Immunopathology 3-4/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.